FDA accepts Aimmune's peanut allergy therapy for review

Aimmune said the recent government shutdown may add about a month onto the approval timeline for its peanut allergy therapy. On Monday, FDA accepted for review a BLA for AR101 to treat peanut

Read the full 332 word article

User Sign In